Fact CheckerSign in

NCT06340646Recruiting

Washington University Participant Engagement and Cancer Genomic Sequencing Center (WU-PE-CGS)

Source: ClinicalTrials.gov · Last updated 14 Jul 2026

Brief summary (registry, in English)

The overall goal of the WU-PE-CGS is to build a rigorous, scientific evidence base for approaches that direct engagement of cancer patients and post-treatment cancer survivors as participants in cancer research, and to investigate the impact of directly engaging participants in decisions regarding returning of genomic results on participants' health and satisfaction. Participants in this study will be presented with the choice of types of genomic results to receive, and the Engagement Optimization Unit (EOU) will investigate the impact of this intervention on participant knowledge, expectations of benefit, personal utility, and decisional conflict.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
990 (estimated)
First submitted
25 Mar 2024
Start date
18 Oct 2022
Primary completion date
31 Jan 2027
Lead sponsor
Washington University School of Medicine
NCT number
NCT06340646

What you commit to

  • Study type: Interventional
  • Planned participants: 990
  • From 18 Oct 2022 to the primary completion date, 31 Jan 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Criteria the registry did not label

  • Eligibility Criteria:
  • Patients with cholangiocarcinoma, multiple myeloma, or early onset colon or rectal cancer.
    • If diagnosed with multiple myeloma, must be African-American.
    • If diagnosed with colon or rectal cancer, must be African-American AND must be no older than 65 years old at the time of diagnosis.
    • At least 18 years old
    • Able to understand and willing to sign an IRB-approved written informed consent document

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Washington University School of Medicine
Coordinator of this site? Confirm its status
St LouisUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.